Maria Koehler - 12 Mar 2025 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Reporting relationship: EVP, CHIEF MEDICAL OFFICER
Issuer ticker: RPTX
Reported as of: 12 Mar 2025
Net transaction value: -$4,099
SEC form: 4
Accepted by SEC: 14 Mar 2025, 16:30:21 UTC
Prior SEC filing: 10 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Steve Forte, Attorney-in-Fact

Key filing fact

Maria Koehler filed Form 4 for Repare Therapeutics Inc. (RPTX) on 14 Mar 2025.

Key facts

This page summarizes Maria Koehler's Form 4 filing for Repare Therapeutics Inc. (RPTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Mar 2025, 16:30.

Change

Previous filing in this sequence was filed on 10 Jun 2024.
Current net transaction value: -$4,099.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPTX transaction

Common Shares

Sale

Transaction value: $4,099
Shares: -3,596
Change %: -1.6%
Price: $1.14
Shares after: 227,813
Date: 12 Mar 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represent shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of restricted stock units and does not represent a discretionary sale by the holder.